$4.440
-0.098 (-2.20%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
GT Biopharma Inc (GTBP) Moving Averages Convergence Divergence (MACD) indicator is -0.54, suggesting GTBP is Strong sell.
GT Biopharma Inc (GTBP) 20-Day simple moving average is 5.79, while GT Biopharma Inc (GTBP) share price is $—, making it Sell.
GT Biopharma Inc (GTBP) 60-Day simple moving average is 6.63, while GT Biopharma Inc (GTBP) share price is $—, making it Sell.
Technical Analysis for GTBP
AI Technical GTBPAs of 2026-11-07, the technical board for GT Biopharma Inc (GTBP) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $4.44 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 34.984, MACD stands at -0.544 (Sell), Stochastic %K stands at 4.345 (Buy), Stochastic %D stands at 4.629 and CCI stands at -130.029 (Buy).
GTBP trades below the 60-day SMA (6.63) and below the 200-day SMA (9.41). Immediate resistance sits at Classic R1 5.88, then R2 6.62. Support sits at Classic S1 4.31, then S2 3.48.
GT Biopharma Inc (GTBP) Support & Resistance Level
GT Biopharma Inc (GTBP) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 34.984 |
| STOCHk_14_3_3 | 4.345 |
| STOCHd_14_3_3 | 4.629 |
| CCI_20 | -130.029 |
| AO_5_34 | -1.227 |
| MOM_10 | -1.040 |
| MACD_12_26_9 | -0.544 |
GT Biopharma Inc (GTBP) Relative Strength Index (RSI_14) is 34.984, creating a Neutral signal.
GT Biopharma Inc (GTBP) Stochastic %K is 4.345, creating a Buy signal.
GT Biopharma Inc (GTBP) Stochastic %D is 4.629, creating a Buy signal.
GT Biopharma Inc (GTBP) CCI_20 is -130.029, creating a Buy signal.
GT Biopharma Inc (GTBP) Awesome Oscillator (AO) is -1.227, creating a Sell signal.
GT Biopharma Inc (GTBP) Momentum (MOM) is -1.040, creating a Sell signal.
GT Biopharma Inc (GTBP) Moving Average Convergence Divergence (MACD) is -0.544, creating a Sell signal.
GT Biopharma Inc (GTBP) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.840 | Sell |
| MA_10 | 5.146 | Sell |
| MA_20 | 5.788 | Sell |
| MA_60 | 6.632 | Sell |
| MA_200 | 9.413 | Sell |
| MA_250 | 11.175 | Sell |
GT Biopharma Inc (GTBP) 5-Day simple moving average is 4.840, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
GT Biopharma Inc (GTBP) 10-Day simple moving average is 5.146, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
GT Biopharma Inc (GTBP) 20-Day simple moving average is 5.788, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
GT Biopharma Inc (GTBP) 60-Day simple moving average is 6.632, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
GT Biopharma Inc (GTBP) 200-Day simple moving average is 9.413, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
GT Biopharma Inc (GTBP) 250-Day simple moving average is 11.175, while GT Biopharma Inc (GTBP) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.